Loading

Moment of Truth: 340 B at a Crossroad

June 24, 2026
26AB
Type: Breakout Session
Focus Area: Patient Advocacy
The 340B program was initially intended to help safety net hospitals further serve vulnerable communities. However, the program has now ballooned into a massive profit generator for hospitals that often aren’t passing the savings on to patients. Patient advocates, government, and others have started calling into question the use of 340B funds. What’s more, the program fundamentally lacks transparency and is also a driver of hospital consolidation, which can end up costing patients more. During this session, panelists will discuss the how the 340B program ballooned into a massive profit generator for hospitals while driving up costs for state and local governments, employers, and taxpayers, and what policy changes would help protect patient access.
Moderator
Ashley John
Director, Issue Advocacy
Novartis
Speakers
Rory Martin, PhD
Senior Principal, Market Access Center of Excellence
IQVIA
Patrick Wildman
Senior Vice President, Advocacy & Government Relations
Lupus Foundation of America

white squarewhite

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS

Loading